Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous version v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:11:36.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision history updated with a new Revision v3.5.0 and removal of Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:43.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:52:49.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The previous notices about government funding and operating status were removed.
    Difference
    0.6%
    Check dated 2026-02-11T02:23:08.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a government funding status notice and the latest site revision tag (v3.4.1); no trial data or record content was changed.
    Difference
    0.6%
    Check dated 2026-02-03T23:07:53.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle, green highlights for additions, red highlights for deletions, and a new revision label (Revision: v3.4.0) on the history page, with the 'No FEAR Act data' note removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-01-27T21:52:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.